Optipharm.CO.,LTD (KOSDAQ:153710)
4,760.00
-30.00 (-0.63%)
At close: Sep 11, 2026
Optipharm.CO.,LTD Market Cap
Optipharm.CO.,LTD has a market cap or net worth of 69.83 billion as of September 11, 2026. Its market cap has decreased by -8.81% in one year.
Market Cap
69.83B
Enterprise Value
70.79B
Revenue
23.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,760.00
ChartMarket Cap Chart
Since October 26, 2018, Optipharm.CO.,LTD's market cap has decreased from 166.34B to 69.83B, a decrease of -58.02%. That is a compound annual growth rate of -10.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 69.83B | -6.67% |
| Dec 30, 2025 | 74.82B | 9.80% |
| Dec 30, 2024 | 68.14B | -33.93% |
| Dec 28, 2023 | 103.13B | 0.29% |
| Dec 29, 2022 | 102.84B | -25.09% |
| Dec 30, 2021 | 137.29B | -37.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 85.14B |
| KOREA PHARMA | 83.11B |
| Samik Pharmaceutical Company LTD. | 79.63B |
| Daehan Nupharm | 78.46B |
| BL Pharmtech | 75.91B |
| GL Pharm Tech | 72.59B |
| Polaris AI Pharma | 72.53B |
| Pharos iBio | 71.85B |